glp 1 press conference Expert panel addresses GLP-1 RAs' factors, features, and future Trump discussed the price of

The article says those patients should have a thorough pre-therapy assessment by an endocrinologist or cardiologist before either therapy is initiated, rather than starting one and layering the second on later without that evaluation

When optimal levels are achieved, you may choose ongoing therapy or discontinue therapy

Effects may be less dramatic than the first course if the initial burden was substantially reduced Maintenance: Some community protocols transition to once-yearly courses for ongoing senescent cell management There is no research to validate this approach

If you have been advised against systemic Menopause Hormone Therapy (MHT) due to a history of blood clots, stroke, or hormone-sensitive cancers, a GLP-1 may be a viable alternative for cardiometabolic protection